Granahan Investment Management HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Granahan Investment Management ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q1 2022$9,046
-22.6%
1,456,749
-12.1%
0.22%
-6.6%
Q4 2021$11,688
+6.0%
1,657,823
+4.9%
0.24%
+15.3%
Q3 2021$11,026
-14.0%
1,579,655
+2.6%
0.21%
-12.6%
Q2 2021$12,825
+54.6%
1,539,560
+1.3%
0.24%
+35.8%
Q1 2021$8,296
+26.9%
1,519,323
-0.3%
0.18%
+19.7%
Q4 2020$6,535
+23.6%
1,523,352
-13.3%
0.15%
-17.9%
Q3 2020$5,289
-1.6%
1,757,176
+1.4%
0.18%
-7.7%
Q2 2020$5,373
+31.7%
1,733,143
-6.1%
0.19%
-11.8%
Q1 2020$4,080
-29.0%
1,846,148
-2.1%
0.22%
-17.0%
Q4 2019$5,749
+5.5%
1,884,833
+6.4%
0.26%
-11.7%
Q3 2019$5,449
+194.9%
1,771,964
+91.8%
0.30%
+229.7%
Q2 2019$1,848
-56.5%
923,773
-6.4%
0.09%
-60.1%
Q1 2019$4,253
+22.5%
986,701
-9.6%
0.23%
-7.3%
Q4 2018$3,472
-40.7%
1,091,683
-2.0%
0.25%
-22.4%
Q3 2018$5,851
+1.7%
1,114,490
+3.6%
0.32%
-8.6%
Q2 2018$5,753
+19.7%
1,075,363
+11.8%
0.35%0.0%
Q1 2018$4,808
+55.7%
961,647
+2.8%
0.35%
+42.8%
Q4 2017$3,088
+53.2%
935,717
+74.1%
0.24%
+44.6%
Q3 2017$2,016
+166.0%
537,467
+80.7%
0.17%
+140.0%
Q2 2017$758
-71.3%
297,412
-70.7%
0.07%
-73.6%
Q1 2017$2,641
-43.7%
1,015,728
-33.9%
0.26%
+64.6%
Q4 2016$4,690
+30.5%
1,537,815
+16.4%
0.16%
+36.4%
Q3 2016$3,593
-2.4%
1,321,115
+2.7%
0.12%
-11.9%
Q2 2016$3,680
-9.2%
1,286,725
-4.1%
0.13%
-8.8%
Q1 2016$4,052
-17.4%
1,341,795
-5.1%
0.15%
-13.0%
Q4 2015$4,904
-23.8%
1,413,215
-17.0%
0.17%
-15.1%
Q3 2015$6,438
-35.5%
1,703,046
-2.8%
0.20%
-29.7%
Q2 2015$9,986
+5.5%
1,751,946
+7.7%
0.28%
+4.4%
Q1 2015$9,467
+1.7%
1,626,636
-1.0%
0.27%
-0.4%
Q4 2014$9,312
+38.4%
1,642,276
-0.1%
0.27%
+30.8%
Q3 2014$6,726
-13.5%
1,644,590
-3.7%
0.21%
-8.4%
Q2 2014$7,772
-6.6%
1,708,216
-2.7%
0.23%
+1.3%
Q1 2014$8,323
+2.7%
1,755,916
+1.9%
0.22%
+7.7%
Q4 2013$8,103
+52.6%
1,723,960
+70.8%
0.21%
+47.5%
Q3 2013$5,309
+15.2%
1,009,325
+3.0%
0.14%
+6.0%
Q2 2013$4,607980,3050.13%